首页 | 本学科首页   官方微博 | 高级检索  
检索        

二氯乙腈诱导HepG2细胞凋亡及机制研究
引用本文:翟璐,梁海荣,罗皓.二氯乙腈诱导HepG2细胞凋亡及机制研究[J].实用预防医学,2018,25(10):1153-1155.
作者姓名:翟璐  梁海荣  罗皓
作者单位:广东医科大学公共卫生学院,东莞市环境医学重点实验室,广东 东莞 523808
基金项目:广东省医学科研基金项目(A2017100)
摘    要:目的 研究二氯乙腈(DCAN)对人肝肿瘤HepG2细胞凋亡的作用及其机制。 方法 用二甲基亚砜(DMSO)溶解DCAN,以DMSO处理的HepG2细胞作为对照组, 50和800 μmol/L 的DCAN处理的HepG2细胞作为处理组,采用Cell Counting Kit-8(CCK-8)试剂盒检测细胞活力,流式细胞术(FCM)检测细胞周期分布情况,Annexin V-FITC/PI双标记法测定细胞凋亡率;荧光测定法检测HepG2细胞内天冬氨酸特异性半胱氨酸蛋白酶-3(caspase-3)活性。 结果 DCAN处理浓度和处理时间存在交互效应(P<0.001),与对照组比较,DCAN可明显抑制HepG2增殖,呈现时间和剂量效应(P<0.05);与对照组比较,800 μmol/L DCAN处理组G0/G1期比例明显减少,G2/M期细胞比例明显增加;DCAN诱导的HepG2细胞凋亡随着浓度的增加而增加,呈剂量-效应关系,回归方程为=0.031x+5决定系数(R2)=0.915,F=64.782,P<0.001];DCAN诱导的HepG2细胞内caspase-3酶活性随着处理浓度的增加而增加,呈剂量-效应关系,回归方程为=0.001 6x+1(R2=1.000,F=21 266.064,P<0.001)。 结论 DCAN可抑制HepG2细胞增殖并诱导细胞凋亡,其机制可能与G2/M期细胞阻滞、抑制RNA和蛋白质的合成并激活细胞内caspase-3凋亡途径有关。

关 键 词:二氯乙腈  人肝肿瘤HepG2细胞  caspase-3  细胞凋亡  
收稿时间:2017-11-30

Apoptosis of human hepatoma HepG2 cells induced by dichloroacetonitrile and its mechanism
ZHAI Lu,LIANG Hai-rong,LUO Hao.Apoptosis of human hepatoma HepG2 cells induced by dichloroacetonitrile and its mechanism[J].Practical Preventive Medicine,2018,25(10):1153-1155.
Authors:ZHAI Lu  LIANG Hai-rong  LUO Hao
Institution:Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan, Guangdong 523808, China
Abstract:Objective To study the apoptosis of human hepatoma HepG2 cells induced by dichloroacetonitrile (DCAN) and its related mechanism. Methods Dimethyl sulfoxide (DMSO)-treated HepG2 cells were selected as the control group, while 50 μmol/L and 800 μmol/L DCAN-treated HepG2 cells served as the DCAN-treated groups. The cell proliferation was detected with Cell Counting Kit-8 (CCK-8 ). Cell cycle and apoptosis rate were analyzed by flow cytometry with annexin V-fluorescein isothiocyanate/propidium iodide (FITC/PI) double staining. The relative activity of caspase-3 in HepG2 cells was examined with fluorospectrophotometer assay. Results The interaction effect existed between DCAN concentration and treatment time (P<0.001). DCAN could significantly inhibit the proliferation of HepG2 cells in a dose- and time-dependent manner compared with the control group (P<0.05). The proportion of HepG2 cells in G0/G1 phase was decreased in the 800 μmol/L DCAN-treated group compared with the control group, while the proportion of HepG2 cells in G2/M phase was increased. Under the DCAN concentrations, the apoptosis rate of HepG2 cells were increased in a dose-dependent manner, with the regressionequation =0.031x+5 (R2=0.915, F=64.782, P<0.001), while the caspase 3 activity was also increased in a dose-dependent manner, with regression equation =0.0016x+1 (R2=1.000,F=21,266.064,P<0.001). Conclusions DCAN can inhibit the proliferation of HepG2 cells and induce their apoptosis, and the mechanism may be related to the arrest of G2/M phase, inhibition of RNA and protein synthesis and activation of caspase-3 pathway.
Keywords:dichloroacetonitrile  human hepatoma HepG2 cell  caspase-3  cell apoptosis  
本文献已被 CNKI 等数据库收录!
点击此处可从《实用预防医学》浏览原始摘要信息
点击此处可从《实用预防医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号